Day: November 4, 2026
Servier Stumbles in Muscle Disease as Drug From $1.5B Deal Fails Pivotal Test
A Servier muscular dystrophy drug fell short of the goals of a pivotal study, a surprising outcome that comes months after the company closed the deal for the molecule it acquired to become the centerpiece of its emerging neuromuscular disease strategy. The drug, sevasemten, was being evaluated as a treatment for Becker muscular dystrophy. Servier’s
Liomen Review – Does This Anti-aging Skin Cream For Men Work? • SpotMeBro.com
How you look should be at the top of every man’s list for fast-tracking your career, increasing your income, boosting confidence and being a social magnet. Having healthy smooth skin gives you inner confidence that others are instinctually drawn to and can be life changing both at work and at home. With so many skincare